Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Polypeptide combinative with PKR kinase structure field specificity and uses thereof

A kinase domain and specific technology, applied in peptides, material inspection products, biological tests, etc., can solve the problems of no PKR inhibitors and PKR polypeptide inhibitors reported

Inactive Publication Date: 2008-10-29
NANKAI UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although the PKR kinase domain plays a role in diseases such as Alzheimer's disease, there are no reports of PKR inhibitors and PKR polypeptide inhibitors

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Polypeptide combinative with PKR kinase structure field specificity and uses thereof
  • Polypeptide combinative with PKR kinase structure field specificity and uses thereof
  • Polypeptide combinative with PKR kinase structure field specificity and uses thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Embodiment 1: recombinant PKR cat Preliminary study on the expression, purification and activity of

[0027] 1. Recombinant PKR cat Plasmid construction

[0028] Use the existing pET28a-PKR template, the following PCR primers and Pfu polymerase to PCR amplify PKR cat :

[0029] Forward primer: 5′-CATGCCATGGGCGACATGAAAGAAACAAAGTATACTG-3′

[0030] Reverse primer: 5′-GGCTCTCGAGACATGTGTGTCGTTCATTTTTCTC-3′

[0031] The amplified DNA fragment was digested with Nco I / Xho I and cloned into plasmid pET28a (Novagen). The recombinant plasmid thus constructed was named pET28a-PKR cat And introduced Escherichia coli BL21. Recombinant plasmid pET28a-PKR cat Allowed in mature PKR cat Recombinant PKR with an additional methionine residue at the N-terminus and an additional 6 histidines at the C-terminus cat expression.

[0032] 2. Recombinant PKR cat purification of

[0033] ①. Directly containing pET28a-PKR cat BL21 in 5 mL LB medium (50 μg / ml kanamycin), 37 ° C, 250 rpm...

Embodiment 2

[0055] Example 2: Obtaining recombinant phage that can specifically bind to PKRcat through five rounds of screening

[0056] 1. The first round of screening and elution:

[0057] ①. Use NaHCO 3 solution dilution PKR cat Protein to 100 μg / mL solution, requires NaHCO 3 The final concentration was 0.1M. Add 100 μL of this solution to one well of a 96-well plate, and coat overnight at 4°C.

[0058] ②. Add 150 μL of freshly prepared TBS (BTBS) solution containing 0.5% (w / v) BSA to the protein-coated wells in the previous step, and place on a rocking platform at room temperature for 1 hour.

[0059] ③. At the same time, the phage (10 11 pfu) was added to 100 μL BTBS, added to an empty well, and placed on a rocking platform at room temperature for 1 hour, the purpose was to absorb the phage that could bind non-specifically to the ELISA plate.

[0060] ④. Pour off the protein / BTBS solution and wash 6 times with 200 μL TBST (TBS containing 0.1% Tween, pH 7.4), taking care not to...

Embodiment 3

[0087] Embodiment 3: ELISA detection screened phage to PKRcat and control binding ability

[0088] ①. Use NaHCO 3 Solution Dilute protein to 100 μg / mL solution, call for NaHCO 3 The final concentration was 0.1M. Add 100 μL of this solution to two wells of a 96-well plate, and fix overnight at 4°C. At the same time, BSA was added to the other two wells as a control according to the same method.

[0089] ②. Add 100 μL of 3% BSA to each well to block the part of unbound protein, and place on a rocking platform at room temperature for 1 hour.

[0090] ③. According to the measured concentration of the phage eluted in the fifth round, dilute the phage with TBST, add 100 μL to each well, and the phage is about 10 9 -10 10 . Place on rocking platform at room temperature for 1 hour.

[0091] ④. Each well was washed 6 times with 200 μl TBST.

[0092] ⑤. HRP-anti-M13 antibody (Pharmacia Biotech Company) was diluted 1:5000 with TBST, added 100 μL to each well, and placed on a rock...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a polypeptide capable of specifically binding with the structural domain of PKR kinase and an application thereof. The invention relates to a 12-peptide sequence with amino acid sequence of Ser-Val-His-Leu-Tyr-His-Ser-Thr-Lys-Thr-Leu-Arg, which is capable of specifically binding with the PKR kinase structural domain (PKRcat) and inhibiting the activity of the PKR kinase. Therefore, the 12-peptide has practical value in research on the role of PKRcat in cell apoptosis and development of PKRcat inhibitors.

Description

technical field [0001] The invention belongs to the technical field of bioengineering and biomedicine, and relates to the use of phage display technology to screen the PKR kinase domain (PKR cat ) specifically binding polypeptides and applications thereof. Background technique [0002] PKR is an interferon-induced double-stranded RNA-dependent protein kinase and a member of the eukaryotic translation initiation factor eIF2α kinase family. It is a serine-threonine kinase composed of 551 amino acids, and recent studies have also found that it has tyrosine kinase activity [Su, Q. et al. Tyrosine phosphorylation acts as a molecular switch to full-scale activation of the eIF2α RNA-dependent protein kinase. 2006. PNAS]. Structurally, it mainly includes two functional domains: the N-terminal and RNA-binding regulatory domain and the C-terminal catalytic domain. PKR plays a major role in the interferon-induced antiviral defense response and is considered to be the most characteri...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K7/08G01N33/68
Inventor 曹又佳张宏恺常云松杜明娟张翠竹
Owner NANKAI UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com